Metabolite Identification Using Infrared Ion Spectroscopy—Novel Biomarkers for Pyridoxine-Dependent Epilepsy

[Image: see text] Untargeted liquid chromatography–mass spectrometry (LC–MS)-based metabolomics strategies are being increasingly applied in metabolite screening for a wide variety of medical conditions. The long-standing “grand challenge” in the utilization of this approach is metabolite identifica...

Descripción completa

Detalles Bibliográficos
Autores principales: van Outersterp, Rianne E., Engelke, Udo F.H., Merx, Jona, Berden, Giel, Paul, Mathias, Thomulka, Thomas, Berkessel, Albrecht, Huigen, Marleen C.D.G., Kluijtmans, Leo A.J., Mecinović, Jasmin, Rutjes, Floris P.J.T., van Karnebeek, Clara D.M., Wevers, Ron A., Boltje, Thomas J., Coene, Karlien L.M., Martens, Jonathan, Oomens, Jos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613736/
https://www.ncbi.nlm.nih.gov/pubmed/34756024
http://dx.doi.org/10.1021/acs.analchem.1c02896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613736/
https://www.ncbi.nlm.nih.gov/pubmed/34756024
http://dx.doi.org/10.1021/acs.analchem.1c02896

Ejemplares similares